BU to Lead $13.6M DOD Lung Cancer Study | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The US Department of Defense has awarded Boston University Medical School a $13.6 million grant to lead a multi-site study to discover molecular biomarkers that can be used for the early detection of lung cancer.

The five-year study will seek to identify markers that could help physicians decide which patients require biopsies after having CT scans and could predict which smokers who had no abnormalities in their CT scans will be most likely to get lung cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.